Adjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity. Adjuvants are used to enhance efficiency of vaccines as conventional vaccines are highly reactogenic in nature.
This report contains market size and forecasts of Immunostimulatory Adjuvants in global, including the following market information:
Global Immunostimulatory Adjuvants Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Immunostimulatory Adjuvants Market Sales, 2017-2022, 2023-2028, (K Pieces)
Global top five Immunostimulatory Adjuvants companies in 2021 (%)
The global Immunostimulatory Adjuvants market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Aluminum Hydroxide Adjuvant Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immunostimulatory Adjuvants include Bayer, Adjuvance Technologies, Vical, Allergy Therapeutics and BioCentury, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunostimulatory Adjuvants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunostimulatory Adjuvants Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)
Global Immunostimulatory Adjuvants Market Segment Percentages, by Type, 2021 (%)
Aluminum Hydroxide Adjuvant
Alum Adjuvant
Liposomes
Others
Global Immunostimulatory Adjuvants Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)
Global Immunostimulatory Adjuvants Market Segment Percentages, by Application, 2021 (%)
Hospitals
Medical Centers
Others
Global Immunostimulatory Adjuvants Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)
Global Immunostimulatory Adjuvants Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunostimulatory Adjuvants revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Immunostimulatory Adjuvants revenues share in global market, 2021 (%)
Key companies Immunostimulatory Adjuvants sales in global market, 2017-2022 (Estimated), (K Pieces)
Key companies Immunostimulatory Adjuvants sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Adjuvance Technologies
Vical
Allergy Therapeutics
BioCentury